Serum Institute of India leads cross-sector Indian investments into UK

- The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software services to announce significant investment plans in the UK
- It was also revealed that SII has started phase one trials in the UK of a nasal vaccine